$6.74
2.43% yesterday
Nasdaq, May 20, 10:00 pm CET
ISIN
US2290503075
Symbol
CYRX

CryoPort Stock price

$6.74
+1.22 22.10% 1M
+0.17 2.59% 6M
-1.04 13.37% YTD
-5.13 43.22% 1Y
-16.53 71.04% 3Y
-14.05 67.58% 5Y
-0.36 5.07% 10Y
Nasdaq, Closing price Tue, May 20 2025
+0.16 2.43%
ISIN
US2290503075
Symbol
CYRX
Industry

Key metrics

Market capitalization $337.92m
Enterprise Value $372.84m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.74
P/S ratio (TTM) P/S ratio 1.57
P/B ratio (TTM) P/B ratio 0.93
Revenue growth (TTM) Revenue growth -4.53%
Revenue (TTM) Revenue $214.83m
EBIT (operating result TTM) EBIT $-59.85m
Free Cash Flow (TTM) Free Cash Flow $-33.82m
Cash position $244.03m
EPS (TTM) EPS $-2.34
P/E forward negative
P/S forward 2.00
EV/Sales forward 2.20
Short interest 6.34%
Show more

Is CryoPort a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

CryoPort Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a CryoPort forecast:

5x Buy
56%
4x Hold
44%

Analyst Opinions

9 Analysts have issued a CryoPort forecast:

Buy
56%
Hold
44%

Financial data from CryoPort

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
215 215
5% 5%
100%
- Direct Costs 134 134
9% 9%
62%
81 81
5% 5%
38%
- Selling and Administrative Expenses 93 93
8% 8%
43%
- Research and Development Expense 17 17
11% 11%
8%
-29 -29
32% 32%
-13%
- Depreciation and Amortization 31 31
8% 8%
14%
EBIT (Operating Income) EBIT -60 -60
16% 16%
-28%
Net Profit -108 -108
4% 4%
-50%

In millions USD.

Don't miss a Thing! We will send you all news about CryoPort directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

CryoPort Stock News

Neutral
Seeking Alpha
13 days ago
Cryoport, Inc. (NASDAQ:CYRX ) Q1 2025 Results Conference Call May 7, 2025 5:00 PM ET Company Participants Jerrell Shelton - CEO Robert Stefanovich - CFO Mark Sawicki - Chief Scientific Officer Thomas Heinzen - VP IR and Corporate Development Todd Fromer - IR, KCSA Strategic Communications Conference Call Participants Kyle Crews - UBS Richard Baldry - ROTH Capital David Larsen - BTIG Subbu Nambi...
Neutral
PRNewsWire
13 days ago
Commercial Cell & Gene therapy revenue of $7.2 million, up 33% year over year Q1 2025 revenue from continuing operations of $41.0 million, up 10% year over year Supporting 711 global clinical trials as of March 31, 2025 Strategic partnership with DHL; CRYOPDP divestiture expected to close Q2/Q3 2025 NASHVILLE, Tenn. , May 7, 2025 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) (Cryoport), a globa...
Neutral
PRNewsWire
27 days ago
NASHVILLE, Tenn. , April 24, 2025 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global provider of supply chain solutions for the life sciences sector, today announced that the Company will report financial results for the first quarter ended March 31, 2025 on Wednesday, May 7, 2025 after U.S. markets close.
More CryoPort News

Company Profile

CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Irvine, CA.

Head office United States
CEO Jerrell Shelton
Employees 1,186
Founded 1990
Website www.cryoport.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today